Hepatitis B virus seroconversion in HIV-HBV coinfected patients treated with highly active antiretroviral therapy

被引：0

作者：

Piroth, L ^{[1
]}

Grappin, M ^{[1
]}

Buisson, M ^{[1
]}

Duong, M ^{[1
]}

Portier, H ^{[1
]}

Chavanet, P ^{[1
]}

机构：

[1] Univ Hosp, Serv Malad Infect & Trop, Dijon, France

来源：

JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2000年 / 23卷 / 04期

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：356 / 357

页数：2

共 50 条

[1] TENOFOVIR-BASED HIGHLY ACTIVE ANTIRETROVIRAL THERAPY (HAART) IS ASSOCIATED WITH HIGH RATES OF HBV DNA SUPPRESSION AND HBEAG SEROCONVERSION IN THAI HIV-HBV COINFECTED PATIENTS
Matthews, Gail
Avihingsanon, Anchalee
Lewin, Sharon
Sasadeusz, Joe
Marks, Pip
Revill, Peter A.
Ayres, Anna
Bow-den, Scott
Locarnini, Stephen
Thio, Chloe L.
Ruxrungtham, Kiat
Dore, Gregory J.
HEPATOLOGY, 2008, 48 (04) : 712A - 713A
[2] Long-Term Hepatitis B Virus (HBV) Response to Lamivudine-Containing Highly Active Antiretroviral Therapy in HIV-HBV Co-Infected Patients in Thailand
Khamduang, Woottichai
Gaudy-Graffin, Catherine
Ngo-Giang-Huong, Nicole
Jourdain, Gonzague
Moreau, Alain
Luekamlung, Nuananong
Halue, Guttiga
Buranawanitchakorn, Yuwadee
Kunkongkapan, Sura
Buranabanjasatean, Sudanee
Lallemant, Marc
Sirirungsi, Wasna
Goudeau, Alain
PLOS ONE, 2012, 7 (07):
[3] Immunopathogenesis of Hepatic Flare in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals after the Initiation of HBV-Active Antiretroviral Therapy
Crane, Megan
Oliver, Ben
Matthews, Gail
Avihingsanon, Anchalee
Ubolyam, Sasiwimol
Markovska, Vesna
Chang, J. Judy
Dore, Gregory J.
Price, Patricia
Visvanathan, Kumar
French, Martyn
Ruxrungtham, Kiat
Lewin, Sharon R.
JOURNAL OF INFECTIOUS DISEASES, 2009, 199 (07): : 974 - 981
[4] Antiretroviral therapy for hepatitis B virus - HIV - Coinfected patients: Promises and pitfalls
Levy, Vivian
Grant, Robert M.
CLINICAL INFECTIOUS DISEASES, 2006, 43 (07) : 904 - 910
[5] Quantitative HBsAg and HBeAg Predict Hepatitis B Seroconversion after Initiation of HAART in HIV-HBV Coinfected Individuals
Matthews, Gail V.
Ali, Rachel J.
Avihingsanon, Anchalee
Amin, Janaki
Hammond, Rachel
Bowden, Scott
Lewin, Sharon R.
Sasadeusz, Joe
Littlejohn, Margaret
Locarnini, Stephen L.
Ruxrungtham, Kiat
Dore, Gregory J.
PLOS ONE, 2013, 8 (04):
[6] Virological outcome of chronic hepatitis B virus infection in HIV-coinfected patients receiving anti-HBV active antiretroviral therapy
Nunez, Marina
Ramos, Belen
Diaz-Pollan, Beatriz
Camino, Nuria
Martin-Carbonero, Luz
Barreiro, Pablo
Gonzalez-Lahoz, Juan
Soriano, Vincent
AIDS RESEARCH AND HUMAN RETROVIRUSES, 2006, 22 (09) : 842 - 848
[7] Virologic and Clinical Outcomes of Hepatitis B Virus Infection in HIV-HBV Coinfected Transplant Recipients
Coffin, C. S.
Stock, P. G.
Dove, L. M.
Berg, C. L.
Nissen, N. N.
Curry, M. P.
Ragni, M.
Regenstein, F. G.
Sherman, K. E.
Roland, M. E.
Terrault, N. A.
AMERICAN JOURNAL OF TRANSPLANTATION, 2010, 10 (05) : 1268 - 1275
[8] Alpha-fetoprotein and highly active antiretroviral therapy in patients coinfected with HIV-1 and hepatitis C virus
Tachikawa N.
Kikuchi Y.
Masaki N.
Saitoh K.
Oka S.
European Journal of Clinical Microbiology and Infectious Diseases, 2001, 20 (5): : 364 - 366
[9] Alpha-fetoprotein and highly active antiretroviral therapy in patients coinfected with HIV-1 and hepatitis C virus
Tachikawa, N
Kikuchi, Y
Masaki, N
Saitoh, K
Oka, S
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2001, 20 (05) : 364 - 366
[10] Lipopolysaccharide, Immune Activation, and Liver Abnormalities in HIV/Hepatitis B Virus (HBV)-Coinfected Individuals Receiving HBV-Active Combination Antiretroviral Therapy
Crane, Megan
Avihingsanon, Anchalee
Rajasuriar, Reena
Velayudham, Pushparaj
Iser, David
Solomon, Ajantha
Sebolao, Baotuti
Tran, Andrew
Spelman, Tim
Matthews, Gail
Cameron, Paul
Tangkijvanich, Pisit
Dore, Gregory J.
Ruxrungtham, Kiat
Lewin, Sharon R.
JOURNAL OF INFECTIOUS DISEASES, 2014, 210 (05): : 745 - 751

← 1 2 3 4 5 →